Literature DB >> 619961

Influence of secondary inoculum of tumour cells on growth of primary tumour.

R van der Gaag, P McCullagh.   

Abstract

The effect of successive inocula of tumour cells given to rats at intervals of 1 to 10 days was examined. If W256 cells were injected on both occasions, the second inoculum failed to grow if given into the footpad as early as 1 day, or intravenously as soon as 4 days, after the first administration. However, although a second inoculum failed to grow, it produced significant augmentation of the growth of the primary implant if given during its latent or growth phases. If the second inoculum contained cells from a fibrosarcoma unrelated to W256, its growth was effectively curtailed if the initial inoculum had preceded it by 24 h or more. However, secondary inocula of fibrosarcoma cells did not augment the growth of the primary W256 tumour.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 619961      PMCID: PMC2009507          DOI: 10.1038/bjc.1978.13

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  13 in total

1.  Demonstration of resistance against methylcholanthrene-induced sarcomas in the primary autochthonous host.

Authors:  G KLEIN; H O SJOGREN; E KLEIN; K E HELLSTROM
Journal:  Cancer Res       Date:  1960-12       Impact factor: 12.701

2.  Effect of previously injected immune serum and tissue on the survival of tumor grafts in mice.

Authors:  N KALISS; N MOLOMUT; J L HARRISS; S D GAULT
Journal:  J Natl Cancer Inst       Date:  1953-02       Impact factor: 13.506

3.  Inhibition of subcutaneously growing line 1 carcinomas due to metastatic spread.

Authors:  J M Yuhas; N H Pazmiño
Journal:  Cancer Res       Date:  1974-08       Impact factor: 12.701

Review 4.  The role of immunoblasts in host resistance and immunotherapy of primary sarcomata.

Authors:  P Alexander; J G Hall
Journal:  Adv Cancer Res       Date:  1970       Impact factor: 6.242

5.  The effect of tumor size on concomitant tumor immunity.

Authors:  P J Deckers; R C Davis; G A Parker; J A Mannick
Journal:  Cancer Res       Date:  1973-01       Impact factor: 12.701

6.  Dependence of concomitant tumor immunity on continued antigenic stimulation.

Authors:  R K Gershon; K Kondo
Journal:  J Natl Cancer Inst       Date:  1971-06       Impact factor: 13.506

7.  Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs.

Authors:  K T Brunner; J Mauel; J C Cerottini; B Chapuis
Journal:  Immunology       Date:  1968-02       Impact factor: 7.397

8.  In vitro studies of immune reactions against autochthonous and syngeneic mouse tumors induced by methylcholanthrene and plastic discs.

Authors:  I Hellström; K E Hellström; G E Pierce
Journal:  Int J Cancer       Date:  1968-07-15       Impact factor: 7.396

9.  Evidence for an immunological reaction of the host directed against its own actively growing primary tumor.

Authors:  Z B Mikulska; C Smith; P Alexander
Journal:  J Natl Cancer Inst       Date:  1966-01       Impact factor: 13.506

10.  The effect of multiple tumours on mammary tumour growth rates in the C3H mouse.

Authors:  P J Cheshire
Journal:  Br J Cancer       Date:  1970-09       Impact factor: 7.640

View more
  1 in total

1.  Possible role of macrophage-like suppressor cells in the anti-tumour activity of BCG.

Authors:  M Castés; N R Lynch; G Lespinats; S Orbach-Arbouys
Journal:  Br J Cancer       Date:  1981-12       Impact factor: 7.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.